Related Experiment Video
Updated: Sep 18, 2025

07:22
Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection
Published on: April 11, 2025
345
Intravascular Lipoleiomyoma With Expansion Into the Right Atrium and Subsequent Debulking Surgery.
Anna Traub1, Jan Vorwerk2, Jan Morf2
1Department of Rhythmology, University Heart Center Lübeck, University Hospital Schleswig-Holstein, Lübeck, Germany.
JACC. Case Reports
|June 20, 2025
Summary
Recurrent lipoleiomyomas, rare smooth muscle and adipose tumors, can be managed with aromatase inhibitors like letrozole when complete resection is not possible. This approach offers a viable option for hormone receptor-positive cases.
Area of Science:
- Cardiovascular Medicine
- Oncology
- Pathology
Background:
- Lipoleiomyomas are rare benign tumors composed of smooth muscle and adipose tissue, predominantly occurring in the uterus.
- Intravenous leiomyomas are a distinct entity, originating from vascular smooth muscle and capable of extensive growth.
Observation:
- A 61-year-old woman with a history of uterine leiomyoma presented with syncopal episodes due to a large right atrial mass.
- The mass, originating from the iliac veins, required partial resection and was pathologically identified as an angioleiomyomatous tumor.
- Three years later, recurrence was observed, extending from the iliac vessels to the right atrium, necessitating complex thoracoabdominal surgery.
Findings:
- The recurrent tumor was hormone receptor-positive.
- Adjunctive therapy with letrozole, an aromatase inhibitor, was initiated post-surgery.
- Follow-up imaging demonstrated significant tumor regression with the patient remaining asymptomatic.
Implications:
- Aromatase inhibitors may be a valuable therapeutic option for managing recurrent, hormone receptor-positive intravenous leiomyomas, especially when complete surgical resection is not feasible.
- This case highlights the importance of a multidisciplinary approach in managing complex cases of intravenous leiomyomas involving cardiac structures.
- Long-term surveillance is crucial for patients with a history of extensive intravenous leiomyomas due to the potential for recurrence.

